329 related articles for article (PubMed ID: 33975868)
1. Association between proton pump inhibitor use and gastric cancer: a population-based cohort study using two different types of nationwide databases in Korea.
Seo SI; Park CH; You SC; Kim JY; Lee KJ; Kim J; Kim Y; Yoo JJ; Seo WW; Lee HS; Shin WG
Gut; 2021 Nov; 70(11):2066-2075. PubMed ID: 33975868
[TBL] [Abstract][Full Text] [Related]
2. Long-term proton pump inhibitors and risk of gastric cancer development after treatment for
Cheung KS; Chan EW; Wong AYS; Chen L; Wong ICK; Leung WK
Gut; 2018 Jan; 67(1):28-35. PubMed ID: 29089382
[TBL] [Abstract][Full Text] [Related]
3. Use of Proton Pump Inhibitors vs Histamine 2 Receptor Antagonists for the Risk of Gastric Cancer: Population-Based Cohort Study.
Shin GY; Park JM; Hong J; Cho YK; Yim HW; Choi MG
Am J Gastroenterol; 2021 Jun; 116(6):1211-1219. PubMed ID: 34074826
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor use and the risk of metachronous gastric cancer after H. pylori eradication in patients who underwent endoscopic resection for gastric neoplasms: A population-based cohort study.
Gong EJ; Jung HK; Lee B; Hong J; Kim JW; Shin CM; Youn YH; Lee KJ
Aliment Pharmacol Ther; 2023 Oct; 58(7):668-677. PubMed ID: 37589510
[TBL] [Abstract][Full Text] [Related]
5. Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study.
Kim JW; Jung HK; Lee B; Shin CM; Gong EJ; Hong J; Youn YH; Lee KJ
Eur J Clin Pharmacol; 2023 Dec; 79(12):1699-1708. PubMed ID: 37861752
[TBL] [Abstract][Full Text] [Related]
6. Association Between Vonoprazan and the Risk of Gastric Cancer After Helicobacter pylori Eradication.
Arai J; Miyawaki A; Aoki T; Niikura R; Hayakawa Y; Fujiwara H; Ihara S; Fujishiro M; Kasuga M
Clin Gastroenterol Hepatol; 2024 Jun; 22(6):1217-1225.e6. PubMed ID: 38354970
[TBL] [Abstract][Full Text] [Related]
7. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
8. Influence of proton pump inhibitors on gastritis diagnosis and pathologic gastric changes.
Nasser SC; Slim M; Nassif JG; Nasser SM
World J Gastroenterol; 2015 Apr; 21(15):4599-606. PubMed ID: 25914469
[TBL] [Abstract][Full Text] [Related]
9. Dose-dependent association of proton pump inhibitors use with gastric intestinal metaplasia among Helicobacter pylori-positive patients.
Snir Y; Leibovitzh H; Leibovici-Weissman Y; Vilkin A; Cohen AD; Shochat T; Niv Y; Dotan I; Feldhamer I; Boltin D; Levi Z
United European Gastroenterol J; 2021 Apr; 9(3):343-353. PubMed ID: 32962566
[TBL] [Abstract][Full Text] [Related]
10. Characteristic analysis of early gastric cancer after
Liu X; Wang X; Mao T; Yin X; Wei Z; Fu J; Wu J; Li X
Ann Med; 2023 Dec; 55(1):2231852. PubMed ID: 37450336
[TBL] [Abstract][Full Text] [Related]
11. Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated
Cheung KS; Chan EW; Wong AYS; Chen L; Seto WK; Wong ICK; Leung WK
Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):493-499. PubMed ID: 31792089
[TBL] [Abstract][Full Text] [Related]
12. Effect of Helicobacter pylori eradication and high-density lipoprotein on the risk of de novo gastric cancer development.
Nam SY; Park BJ; Nam JH; Kook MC
Gastrointest Endosc; 2019 Sep; 90(3):448-456.e1. PubMed ID: 31034810
[TBL] [Abstract][Full Text] [Related]
13. Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors.
Schneider JL; Kolitsopoulos F; Corley DA
Aliment Pharmacol Ther; 2016 Jan; 43(1):73-82. PubMed ID: 26541643
[TBL] [Abstract][Full Text] [Related]
14. Family History of Gastric Cancer and
Choi IJ; Kim CG; Lee JY; Kim YI; Kook MC; Park B; Joo J
N Engl J Med; 2020 Jan; 382(5):427-436. PubMed ID: 31995688
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
[TBL] [Abstract][Full Text] [Related]
16. Maintenance therapy with proton pump inhibitors and risk of gastric cancer: a nationwide population-based cohort study in Sweden.
Brusselaers N; Wahlin K; Engstrand L; Lagergren J
BMJ Open; 2017 Oct; 7(10):e017739. PubMed ID: 29084798
[TBL] [Abstract][Full Text] [Related]
17. Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.
Leung WK; Wong IOL; Cheung KS; Yeung KF; Chan EW; Wong AYS; Chen L; Wong ICK; Graham DY
Gastroenterology; 2018 Jul; 155(1):67-75. PubMed ID: 29550592
[TBL] [Abstract][Full Text] [Related]
18. Ranitidine Use and Gastric Cancer Among Persons with Helicobacter pylori.
Kumar S; Goldberg DS; Kaplan DE
Dig Dis Sci; 2022 May; 67(5):1822-1830. PubMed ID: 33856609
[TBL] [Abstract][Full Text] [Related]
19. Long-term proton pump inhibitor use and risk of osteoporosis and hip fractures: A nationwide population-based and multicenter cohort study using a common data model.
Park DH; Seo SI; Lee KJ; Kim J; Kim Y; Seo WW; Lee HS; Shin WG; Yoo JJ
J Gastroenterol Hepatol; 2022 Aug; 37(8):1534-1543. PubMed ID: 35501296
[TBL] [Abstract][Full Text] [Related]
20.
Doorakkers E; Lagergren J; Engstrand L; Brusselaers N
Gut; 2018 Dec; 67(12):2092-2096. PubMed ID: 29382776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]